Peptides in 2026, What the FDA Review Means
Peptides are getting a lot of attention right now, and the discussions around them are evolving. In April 2026, the FDA announced that its Pharmacy Compounding Advisory Committee (PCAC) will meet on July 23 and 24, 2026, to discuss several peptide-related bulk drug substances for possible inclusion on the 503A Bulks List. The agency also stated
Peptides in 2026, What the FDA Review Means Read More »


